Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic...
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA
About this item
Full title
Author / Creator
Publisher
BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
BioMed Central
Subjects
More information
Scope and Contents
Contents
Background: Array-CGH represents a comprehensive tool to discover genomic disease alterations that could potentially be applied to body fluids. In this report, we aimed at applying array-CGH to urinary samples to characterize bladder cancer. Methods: Urinary DNA from bladder cancer patients and controls were hybridized on 44K oligonucleotide arrays...
Alternative Titles
Full title
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_csuc_recercat_oai_recercat_cat_2072_346132
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_csuc_recercat_oai_recercat_cat_2072_346132
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
